Receptor BioLogix is developing protein therapeutics for the treatment of cancer, autoimmune and metabolic diseases.
History:
Founded in July 2003. Their technology was acquired by Symphogen in early 2009. While their website is still up, most links point to the Symphogen acquisition (7/2009)
